XSS in Bdtask G-Prescription Gynaecology \& Obs Consultation
CVE-2024-2275
A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Vulnerability class: XSS (Cross-Site Scripting)
EPSS: 0.005 (37.1th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 2.4 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N.
Affected products
- Bdtask G-prescription_gynaecology_\&_obs_consultation — versions 1.0
- Bdtask G-prescription Gynaecology & Obs Consultation Software — versions 1.0
Weakness classification (CWE)
Public proof-of-concept exploits
References
- cna@vuldb.com (Permissions Required, technical-description, vdb-entry)
- cna@vuldb.com (signature, Permissions Required, permissions-required)
- cna@vuldb.com (Exploit, exploit)
Frequently asked questions
- What is CVE-2024-2275?
- CVE-2024-2275 is a low-severity vulnerability in Bdtask G-Prescription Gynaecology \& Obs Consultation, classified under Cross-site Scripting. CVSS score: 2.4/10. Published 2024-03-08.
- How severe is CVE-2024-2275?
- Low severity. CVSS v3 base score is 2.4 out of 10.
- Is CVE-2024-2275 known to be exploited?
- 2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.